Associated Papers
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
Tauziede-Espariat A et al.
Brain Pathology (zurich, Switzerland), 2018
SMARCE1 mutation screening in classification of clear cell meningiomas.
Smith MJ et al.
Histopathology, 2017
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Smith MJ et al.
The Journal of Pathology, 2014
Select a paper to view details